BELLONE, Stefania
BELLONE, Stefania
Dipartimento Materno Infantile e Tecnologie Biomediche (attivo dal 01/01/1900 al 31/12/2012)
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer.
2011-01-01 Ratner, Es; Keane, Fk; Lindner, R; Tassi, Renata Alessandra; Paranjape, T; Glasgow, M; Nallur, S; Deng, Y; Lu, L; Steele, L; Sand, S; Muller, Ru; Bignotti, Eliana; Bellone, Stefania; Boeke, M; Yao, X; Pecorelli, Sergio; Ravaggi, Antonella; Katsaros, D; Zelterman, D; Cristea, Mc; Yu, H; Rutherford, Tj; Weitzel, Jn; Neuhausen, Sl; Schwartz, Pe; Slack, Fj; Santin, Ad; Weidhaas, J. B.
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody
2012-01-01 Varughese, Joyce; Cocco, Emiliano; Bellone, Stefania; Ratner, Elena; Silasi, Dan Arin; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Buza, Natalia; Pecorelli, Sergio; Santin, Alessandro D.
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone
2013-01-01 Roque, Dana M; Bellone, Stefania; Buza, Natalia; Romani, Chiara; Cocco, Emiliano; Bignotti, Eliana; Ravaggi, Antonella; Rutherford, Thomas J; Schwartz, Peter E; Pecorelli, Sergio; Santin, Alessandro D.
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
2019-01-01 Li, C; Bonazzoli, E; Bellone, S; Choi, J; Dong, Wl; Menderes, G; Altwerger, G; Han, C; Manzano, A; Bianchi, A; Pettinella, F; Manara, P; Lopez, S; Yadav, G; Riccio, F; Zammataro, L; Zeybek, B; Yang-Hartwich, Y; Buza, N; Hui, P; Wong, S; Ravaggi, A; Bignotti, E; Romani, C; Todeschini, P; Zanotti, L; Zizioli, V; Odicino, F; Pecorelli, S; Ardighieri, L; Silasi, Da; Litkouhi, B; Ratner, E; Azodi, M; Huang, Gs; Schwartz, Pe; Lifton, Rp; Schlessinger, J; Santin, Ad
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression.
2011-01-01 Carrara, L; Guzzo, F; Roque, Dm; Bellone, Stefania; Emiliano, C; Sartori, Enrico; Pecorelli, Sergio; Schwartz, Pe; Rutherford, Tj; Gynecol Oncol, Santin A. D.
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor
2011-01-01 Cocco, Emiliano; Varughese, Joyce; Buza, Natalia; Bellone, Stefania; Glasgow, Michelle; Bellone, Marta; Todeschini, Paola; Carrara, Luisa; Silasi, Dan Arin; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Pecorelli, Sergio; Lockwood, Charles J; Santin, Alessandro D.
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas
2012-01-01 Guzzo, Federica; Bellone, Stefania; Buza, Natalia; Hui, Pei; Carrara, Luisa; Varughese, Joyce; Cocco, Emiliano; Betti, Marta; Todeschini, Paola; Gasparrini, Sara; Schwartz, Peter E; Rutherford, Thomas J; Angioli, Roberto; Pecorelli, Sergio; Santin, Alessandro D.
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab.
2011-01-01 Todeschini, P; Cocco, E; Bellone, Stefania; Varughese, J; Lin, K; Carrara, L; Guzzo, F; Buza, N; Hui, P; Silasi, Da; Ratner, E; Azodi, M; Schwartz, Pe; Rutherford, Tj; Pecorelli, Sergio; Santin, A. d.
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody
2011-01-01 Varughese, Joyce; Cocco, Emiliano; Bellone, Stefania; Bellone, Marta; Todeschini, Paola; Carrara, Luisa; Schwartz, Peter E; Rutherford, Thomas J; Pecorelli, Sergio; Santin, Alessandro D.
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
2006-01-01 Santin, Alessandro; Bellone, Stefania; Palmieri, M; Ravaggi, Antonella; Romani, Chiara; Tassi, Renata Alessandra; Roman, Jj; Burnett, A; Pecorelli, Sergio; Cannon, Mj
Integrated mutational landscape analysis of uterine leiomyosarcomas
2021-01-01 Choi, Jungmin; Manzano, Aranzazu; Dong, Weilai; Bellone, Stefania; Bonazzoli, Elena; Zammataro, Luca; Yao, Xiaotong; Deshpande, Aditya; Zaidi, Samir; Guglielmi, Adele; Gnutti, Barbara; Nagarkatti, Nupur; Tymon-Rosario, Joan R; Harold, Justin; Mauricio, Dennis; Zeybek, Burak; Menderes, Gulden; Altwerger, Gary; Jeong, Kyungjo; Zhao, Siming; Buza, Natalia; Hui, Pei; Ravaggi, Antonella; Bignotti, Eliana; Romani, Chiara; Todeschini, Paola; Zanotti, Laura; Odicino, Franco; Pecorelli, Sergio; Ardighieri, Laura; Bilguvar, Kaya; Quick, Charles M; Silasi, Dan-Arin; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Ratner, Elena; Azodi, Masoud; Imielinski, Marcin; Schwartz, Peter E; Alexandrov, Ludmil B; Lifton, Richard P; Schlessinger, Joseph; Santin, Alessandro D
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
2013-01-01 Zhao, Siming; Choi, Murim; Overton, John D; Bellone, Stefania; Roque, Dana M; Cocco, Emiliano; Guzzo, Federica; English, Diana P; Varughese, Joyce; Gasparrini, Sara; Bortolomai, Ileana; Buza, Natalia; Hui, Pei; Abu Khalaf, Maysa; Ravaggi, Antonella; Bignotti, Eliana; Bandiera, Elisabetta; Romani, Chiara; Todeschini, Paola; Tassi, Renata; Zanotti, Laura; Carrara, Luisa; Pecorelli, Sergio; Silasi, Dan Arin; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Stiegler, Amy L; Mane, Shrikant; Boggon, Titus J; Schlessinger, Joseph; Lifton, Richard P; Santin, Alessandro D.
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2)
2013-01-01 English, Diana P; Bellone, Stefania; Cocco, Emiliano; Bortolomai, Ileana; Pecorelli, Sergio; Lopez, Salvatore; Silasi, Dan Arin; Schwartz, Peter E; Rutherford, Thomas; Santin, Alessandro D.
Serum amyloid A: a novel biomarker for endometrial cancer.
2010-01-01 Cocco, E; Bellone, Stefania; El Sahwi, K; Cargnelutti, M; Buza, N; Tavassoli, Fa; Schwartz, Pe; Rutherford, Tj; Pecorelli, Sergio; Santin, A. D.
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor
2011-01-01 Cocco, Emiliano; Varughese, Joyce; Buza, Natalia; Bellone, Stefania; Lin, Ken Yu; Bellone, Marta; Todeschini, Paola; Silasi, Dan Arin; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Carrara, Luisa; Tassi, Renata; Pecorelli, Sergio; Lockwood, Charles J; Santin, Alessandro D.
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody.
2011-01-01 Raji, R; Guzzo, F; Carrara, L; Varughese, J; Cocco, E; Bellone, Stefania; Betti, M; Todeschini, P; Gasparrini, S; Ratner, E; Silasi, Da; Azodi, M; Schwartz, P; Rutherford, Tj; Buza, N; Pecorelli, Sergio; Santin, A. D.
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody
2011-01-01 Varughese, Joyce; Cocco, Emiliano; Bellone, Stefania; de Leon, Maria; Bellone, Marta; Todeschini, Paola; Schwartz, Peter E; Rutherford, Thomas J; Pecorelli, Sergio; Santin, Alessandro D.
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
2019-01-01 Zammataro, Luca; Lopez, Salvatore; Bellone, Stefania; Pettinella, Francesca; Bonazzoli, Elena; Perrone, Emanuele; Zhao, Siming; Menderes, Gulden; Altwerger, Gary; Han, Chanhee; Zeybek, Burak; Bianchi, Anna; Manzano, Aranzazu; Manara, Paola; Cocco, Emiliano; Buza, Natalia; Hui, Pei; Wong, Serena; Ravaggi, Antonella; Bignotti, Eliana; Romani, Chiara; Todeschini, Paola; Zanotti, Laura; Odicino, Franco; Pecorelli, Sergio; Donzelli, Carla; Ardighieri, Laura; Angioli, Roberto; Raspagliesi, Francesco; Scambia, Giovanni; Choi, Jungmin; Dong, Weilai; Bilguvar, Kaya; Alexandrov, Ludmil B; Silasi, Dan-Arin; Huang, Gloria S; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Pirazzoli, Valentina; Stiegler, Amy L; Boggon, Titus J; Lifton, Richard P; Schlessinger, Joseph; Santin, Alessandro D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. | 1-gen-2011 | Ratner, Es; Keane, Fk; Lindner, R; Tassi, Renata Alessandra; Paranjape, T; Glasgow, M; Nallur, S; Deng, Y; Lu, L; Steele, L; Sand, S; Muller, Ru; Bignotti, Eliana; Bellone, Stefania; Boeke, M; Yao, X; Pecorelli, Sergio; Ravaggi, Antonella; Katsaros, D; Zelterman, D; Cristea, Mc; Yu, H; Rutherford, Tj; Weitzel, Jn; Neuhausen, Sl; Schwartz, Pe; Slack, Fj; Santin, Ad; Weidhaas, J. B. | |
| Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody | 1-gen-2012 | Varughese, Joyce; Cocco, Emiliano; Bellone, Stefania; Ratner, Elena; Silasi, Dan Arin; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Buza, Natalia; Pecorelli, Sergio; Santin, Alessandro D. | |
| Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone | 1-gen-2013 | Roque, Dana M; Bellone, Stefania; Buza, Natalia; Romani, Chiara; Cocco, Emiliano; Bignotti, Eliana; Ravaggi, Antonella; Rutherford, Thomas J; Schwartz, Peter E; Pecorelli, Sergio; Santin, Alessandro D. | |
| Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors | 1-gen-2019 | Li, C; Bonazzoli, E; Bellone, S; Choi, J; Dong, Wl; Menderes, G; Altwerger, G; Han, C; Manzano, A; Bianchi, A; Pettinella, F; Manara, P; Lopez, S; Yadav, G; Riccio, F; Zammataro, L; Zeybek, B; Yang-Hartwich, Y; Buza, N; Hui, P; Wong, S; Ravaggi, A; Bignotti, E; Romani, C; Todeschini, P; Zanotti, L; Zizioli, V; Odicino, F; Pecorelli, S; Ardighieri, L; Silasi, Da; Litkouhi, B; Ratner, E; Azodi, M; Huang, Gs; Schwartz, Pe; Lifton, Rp; Schlessinger, J; Santin, Ad | |
| Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. | 1-gen-2011 | Carrara, L; Guzzo, F; Roque, Dm; Bellone, Stefania; Emiliano, C; Sartori, Enrico; Pecorelli, Sergio; Schwartz, Pe; Rutherford, Tj; Gynecol Oncol, Santin A. D. | |
| Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor | 1-gen-2011 | Cocco, Emiliano; Varughese, Joyce; Buza, Natalia; Bellone, Stefania; Glasgow, Michelle; Bellone, Marta; Todeschini, Paola; Carrara, Luisa; Silasi, Dan Arin; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Pecorelli, Sergio; Lockwood, Charles J; Santin, Alessandro D. | |
| HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas | 1-gen-2012 | Guzzo, Federica; Bellone, Stefania; Buza, Natalia; Hui, Pei; Carrara, Luisa; Varughese, Joyce; Cocco, Emiliano; Betti, Marta; Todeschini, Paola; Gasparrini, Sara; Schwartz, Peter E; Rutherford, Thomas J; Angioli, Roberto; Pecorelli, Sergio; Santin, Alessandro D. | |
| Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab. | 1-gen-2011 | Todeschini, P; Cocco, E; Bellone, Stefania; Varughese, J; Lin, K; Carrara, L; Guzzo, F; Buza, N; Hui, P; Silasi, Da; Ratner, E; Azodi, M; Schwartz, Pe; Rutherford, Tj; Pecorelli, Sergio; Santin, A. d. | |
| High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody | 1-gen-2011 | Varughese, Joyce; Cocco, Emiliano; Bellone, Stefania; Bellone, Marta; Todeschini, Paola; Carrara, Luisa; Schwartz, Peter E; Rutherford, Thomas J; Pecorelli, Sergio; Santin, Alessandro D. | |
| HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. | 1-gen-2006 | Santin, Alessandro; Bellone, Stefania; Palmieri, M; Ravaggi, Antonella; Romani, Chiara; Tassi, Renata Alessandra; Roman, Jj; Burnett, A; Pecorelli, Sergio; Cannon, Mj | |
| Integrated mutational landscape analysis of uterine leiomyosarcomas | 1-gen-2021 | Choi, Jungmin; Manzano, Aranzazu; Dong, Weilai; Bellone, Stefania; Bonazzoli, Elena; Zammataro, Luca; Yao, Xiaotong; Deshpande, Aditya; Zaidi, Samir; Guglielmi, Adele; Gnutti, Barbara; Nagarkatti, Nupur; Tymon-Rosario, Joan R; Harold, Justin; Mauricio, Dennis; Zeybek, Burak; Menderes, Gulden; Altwerger, Gary; Jeong, Kyungjo; Zhao, Siming; Buza, Natalia; Hui, Pei; Ravaggi, Antonella; Bignotti, Eliana; Romani, Chiara; Todeschini, Paola; Zanotti, Laura; Odicino, Franco; Pecorelli, Sergio; Ardighieri, Laura; Bilguvar, Kaya; Quick, Charles M; Silasi, Dan-Arin; Huang, Gloria S; Andikyan, Vaagn; Clark, Mitchell; Ratner, Elena; Azodi, Masoud; Imielinski, Marcin; Schwartz, Peter E; Alexandrov, Ludmil B; Lifton, Richard P; Schlessinger, Joseph; Santin, Alessandro D | |
| Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma | 1-gen-2013 | Zhao, Siming; Choi, Murim; Overton, John D; Bellone, Stefania; Roque, Dana M; Cocco, Emiliano; Guzzo, Federica; English, Diana P; Varughese, Joyce; Gasparrini, Sara; Bortolomai, Ileana; Buza, Natalia; Hui, Pei; Abu Khalaf, Maysa; Ravaggi, Antonella; Bignotti, Eliana; Bandiera, Elisabetta; Romani, Chiara; Todeschini, Paola; Tassi, Renata; Zanotti, Laura; Carrara, Luisa; Pecorelli, Sergio; Silasi, Dan Arin; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Stiegler, Amy L; Mane, Shrikant; Boggon, Titus J; Schlessinger, Joseph; Lifton, Richard P; Santin, Alessandro D. | |
| Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2) | 1-gen-2013 | English, Diana P; Bellone, Stefania; Cocco, Emiliano; Bortolomai, Ileana; Pecorelli, Sergio; Lopez, Salvatore; Silasi, Dan Arin; Schwartz, Peter E; Rutherford, Thomas; Santin, Alessandro D. | |
| Serum amyloid A: a novel biomarker for endometrial cancer. | 1-gen-2010 | Cocco, E; Bellone, Stefania; El Sahwi, K; Cargnelutti, M; Buza, N; Tavassoli, Fa; Schwartz, Pe; Rutherford, Tj; Pecorelli, Sergio; Santin, A. D. | |
| Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor | 1-gen-2011 | Cocco, Emiliano; Varughese, Joyce; Buza, Natalia; Bellone, Stefania; Lin, Ken Yu; Bellone, Marta; Todeschini, Paola; Silasi, Dan Arin; Azodi, Masoud; Schwartz, Peter E; Rutherford, Thomas J; Carrara, Luisa; Tassi, Renata; Pecorelli, Sergio; Lockwood, Charles J; Santin, Alessandro D. | |
| Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. | 1-gen-2011 | Raji, R; Guzzo, F; Carrara, L; Varughese, J; Cocco, E; Bellone, Stefania; Betti, M; Todeschini, P; Gasparrini, S; Ratner, E; Silasi, Da; Azodi, M; Schwartz, P; Rutherford, Tj; Buza, N; Pecorelli, Sergio; Santin, A. D. | |
| Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody | 1-gen-2011 | Varughese, Joyce; Cocco, Emiliano; Bellone, Stefania; de Leon, Maria; Bellone, Marta; Todeschini, Paola; Schwartz, Peter E; Rutherford, Thomas J; Pecorelli, Sergio; Santin, Alessandro D. | |
| Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy | 1-gen-2019 | Zammataro, Luca; Lopez, Salvatore; Bellone, Stefania; Pettinella, Francesca; Bonazzoli, Elena; Perrone, Emanuele; Zhao, Siming; Menderes, Gulden; Altwerger, Gary; Han, Chanhee; Zeybek, Burak; Bianchi, Anna; Manzano, Aranzazu; Manara, Paola; Cocco, Emiliano; Buza, Natalia; Hui, Pei; Wong, Serena; Ravaggi, Antonella; Bignotti, Eliana; Romani, Chiara; Todeschini, Paola; Zanotti, Laura; Odicino, Franco; Pecorelli, Sergio; Donzelli, Carla; Ardighieri, Laura; Angioli, Roberto; Raspagliesi, Francesco; Scambia, Giovanni; Choi, Jungmin; Dong, Weilai; Bilguvar, Kaya; Alexandrov, Ludmil B; Silasi, Dan-Arin; Huang, Gloria S; Ratner, Elena; Azodi, Masoud; Schwartz, Peter E; Pirazzoli, Valentina; Stiegler, Amy L; Boggon, Titus J; Lifton, Richard P; Schlessinger, Joseph; Santin, Alessandro D |